Latest Insider Transactions at Axim Biotechnologies, Inc. (AXIM)
This section provides a real-time view of insider transactions for Axim Biotechnologies, Inc. (AXIM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AXIM BIOTECHNOLOGIES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AXIM BIOTECHNOLOGIES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 30
2024
|
Catalina Valencia President and Director |
BUY
Open market or private purchase
|
Direct |
1,086,216
+3.66%
|
-
|
|
Aug 24
2022
|
Catalina Valencia President and Director |
BUY
Open market or private purchase
|
Direct |
3,861,004
+14.03%
|
$0
$0.03 P/Share
|
|
Aug 22
2022
|
Blake Schroeder Director |
BUY
Conversion of derivative security
|
Direct |
854,012
+50.0%
|
$0
$0.03 P/Share
|
|
Mar 19
2020
|
John Walter Huemoeller Ii Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000,000
+50.0%
|
-
|